COGT
Price
$35.71
Change
-$0.13 (-0.36%)
Updated
Jun 23, 12:20 PM (EDT)
Capitalization
6.12B
49 days until earnings call
Intraday BUY SELL Signals
IPHA
Price
$1.81
Change
-$0.00 (-0.00%)
Updated
Jun 22 closing price
Capitalization
173.21M
86 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COGT vs IPHA

COGT vs IPHA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
COGT vs. IPHA commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Buy and IPHA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (COGT: $35.83 vs. IPHA: $1.83)
Brand notoriety: COGT and IPHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 159% vs. IPHA: 9%
Market capitalization -- COGT: $6.12B vs. IPHA: $173.21M
COGT [@Biotechnology] is valued at $6.12B. IPHA’s [@Biotechnology] market capitalization is $173.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 1 FA rating(s) are green whileIPHA’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 1 green, 4 red.
  • IPHA’s FA Score: 0 green, 5 red.
According to our system of comparison, both COGT and IPHA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while IPHA’s TA Score has 3 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 4 bearish.
  • IPHA’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, COGT is a better buy in the short-term than IPHA.

Price Growth

COGT (@Biotechnology) experienced а +8.00% price change this week, while IPHA (@Biotechnology) price change was +1.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was +3.26%, and the average quarterly price growth was +1969.89%.

Reported Earning Dates

COGT is expected to report earnings on Aug 11, 2026.

IPHA is expected to report earnings on Sep 17, 2026.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($6.12B) has a higher market cap than IPHA($173M). IPHA YTD gains are higher at: 4.286 vs. COGT (0.859).
COGTIPHACOGT / IPHA
Capitalization6.12B173M3,538%
EBITDA-345.43MN/A-
Gain YTD0.8594.28620%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash866MN/A-
Total Debt239MN/A-
FUNDAMENTALS RATINGS
COGT vs IPHA: Fundamental Ratings
COGT
IPHA
OUTLOOK RATING
1..100
3129
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
22100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
3748
P/E GROWTH RATING
1..100
10038
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COGT's Valuation (74) in the Miscellaneous industry is in the same range as IPHA (76) in the null industry. This means that COGT’s stock grew similarly to IPHA’s over the last 12 months.

COGT's Profit vs Risk Rating (22) in the Miscellaneous industry is significantly better than the same rating for IPHA (100) in the null industry. This means that COGT’s stock grew significantly faster than IPHA’s over the last 12 months.

COGT's SMR Rating (99) in the Miscellaneous industry is in the same range as IPHA (99) in the null industry. This means that COGT’s stock grew similarly to IPHA’s over the last 12 months.

COGT's Price Growth Rating (37) in the Miscellaneous industry is in the same range as IPHA (48) in the null industry. This means that COGT’s stock grew similarly to IPHA’s over the last 12 months.

IPHA's P/E Growth Rating (38) in the null industry is somewhat better than the same rating for COGT (100) in the Miscellaneous industry. This means that IPHA’s stock grew somewhat faster than COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTIPHA
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
75%
Declines
ODDS (%)
Bearish Trend 21 days ago
80%
Bearish Trend 29 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signal:
Gain/Loss:
IPHA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XLKI27.630.10
+0.35%
State Street®TechSelSectSPDR®PrmETF
IJR143.260.05
+0.03%
iShares Core S&P Small-Cap ETF
NUKZ71.09-0.36
-0.50%
Range Nuclear Renaissance ETF
COPJ41.52-0.98
-2.31%
Sprott Junior Copper Miners ETF
WANT40.76-2.28
-5.30%
Direxion Daily Cnsmr Discret Bull 3X ETF

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
+0.83%
MDGL - IPHA
43%
Loosely correlated
+1.59%
FENC - IPHA
41%
Loosely correlated
+5.19%
APLM - IPHA
36%
Loosely correlated
+30.47%
CCXI - IPHA
34%
Loosely correlated
+0.63%
COGT - IPHA
33%
Poorly correlated
+3.72%
More